Drugs / Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01659645 | Aug 2012 → Jan 2015 | breast cancer | Emory University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-1-amino-3-\[18F\]fluorocyclobutyl-1-carboxylic acid | “Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast” NCT01659645 ↗ |
| Known as | FACBC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01659645 ↗ |
| Modality | Diagnostic / imaging agent | “amino acid based PET radiotracer” NCT01659645 ↗ |
| Route | Intravenous | “FACBC will be given intravenously (IV) over 2 minutes prior to performing the PET scan” NCT01659645 ↗ |